Evropska unija - slovenščina - EMA (European Medicines Agency)

teva b.v. - salmeterol xinafoate, fluticasone propionat - astma - zdravila za obstruktivne pljučne bolezni, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Evropska unija - slovenščina - EMA (European Medicines Agency)

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - zdravila za obstruktivne pljučne bolezni, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

beklometazondipropionat; formoterolijev fumarat dihidrat - prašek za inhaliranje - beklometazondipropionat 200 µg / 1 vsebnik  formoterolijev fumarat dihidrat12 µg / 1 vsebnik; formoterolijev fumarat dihidrat 12 µg / 1 vsebnik - formoterol in beklometazon

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

flutikazonpropionat; salmeterol - inhalacijska suspenzija pod tlakom - flutikazonpropionat 250 µg / 1 vpih  salmeterol25 µg / 1 vpih; salmeterol 25 µg / 1 vpih - salmeterol in flutikazon